Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS)
Rheumatology International · 2025
DOI: 10.1007/s00296-025-06014-y ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Rheumatology International, 2025. Verfasst von Genki Kidoguchi und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, 1-2- 3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. kidogen@hiro…. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis, Antibodies, Antineutrophil Cytoplasmic, Granulomatosis with Polyangiitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hiroshima University.
Abstract (Originalsprache)
Objective
To compare clinicopathological phenotype-based, anti-neutrophil cytoplasmic antibody (ANCA) serotype-based, and unsupervised data-driven classifications in relation to clinical outcomes and patient heterogeneity in a large Japanese cohort with ANCA-associated vasculitis (AAV).
Methods
This multicentre, retrospective cohort study analysed data from a nationwide Japanese registry of 729 newly diagnosed patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA), all positive for myeloperoxidase (MPO)- or proteinase 3 (PR3)-ANCA. Patients were classified by phenotype, serotype, combined phenotype-serotype groupings, and data-driven clustering based on baseline clinical and laboratory features. Associations with clinical outcomes—including mortality, relapse, and response to rituximab (RTX) versus cyclophosphamide (IVCY)—were evaluated using inverse probability of treatment weighting (IPW).
Results
Phenotype-based classification more accurately distinguished all-cause mortality risk (MPA vs. GPA: hazard ratio [HR] 2.53, 95% CI 1.34–4.76). Combined phenotype-serotype analysis identified MPO-MPA patients with the highest mortality (HR 3.45, 95% CI 1.09-11.0, vs. PR3-GPA) and PR3-GPA with the highest severe relapse. Discordant groups, such as MPO-GPA, demonstrated unique clinical characteristics. After IPW adjustment, no significant difference in 24-week remission rates was observed between RTX and IVCY across classifications, both overall (RR 1.02, 95% CI 0.95–1.09) and within subgroups. Unsupervised clustering identified four distinct clinical subgroups, with limited concordance with conventional phenotype or serotype classifications.
Conclusion
Phenotype and serotype classifications provide complementary, not competing, prognostic insights in Japanese patients with AAV. Data-driven clustering revealed additional clinical heterogeneity not captured by traditional systems, underscoring the need for integrated, multi-dimensional stratification approaches to improve personalised risk assessment and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, 1-2- 3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. kidogen@hiroshima-u.ac.jp.
- Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, 1-2- 3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
- Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Rheumatology, University of Yamanashi Hospital, Yamanashi, Japan.
- Department of Internal Medicine and Rheumatology, Juntendo University, Tokyo, Japan.
- Center for Rheumatic Disease, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, Japan.
Förderung
- Hiroshima University
Zitieren
APA
Kidoguchi, G., Yoshida, Y., Omura, S., Nakagomi, D., Abe, Y., Wada, M., Takizawa, N., Nomura, A., Kukida, Y., Kondo, N., Takagi, H., Endo, K., Azuma, N., Takeuchi, T., Fukui, S., Kamada, K., Yanai, R., Matsuo, Y., Shimojima, Y., …, & Hirata, S. (2025). Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS). Rheumatology International. https://doi.org/10.1007/s00296-025-06014-y
Vancouver
Kidoguchi G, Yoshida Y, Omura S, Nakagomi D, Abe Y, Wada M, et al. Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS). Rheumatology International. 2025. doi:10.1007/s00296-025-06014-y
BibTeX
@article{Kidoguchi2025,
author = {Kidoguchi, Genki and Yoshida, Yusuke and Omura, Satoshi and Nakagomi, Daiki and Abe, Yoshiyuki and Wada, Makoto and Takizawa, Naoho and Nomura, Atsushi and Kukida, Yuji and Kondo, Naoya and Takagi, Hirosuke and Endo, Koji and Azuma, Naoto and Takeuchi, Tohru and Fukui, Shoichi and Kamada, Kazuro and Yanai, Ryo and Matsuo, Yusuke and Shimojima, Yasuhiro and Nishioka, Ryo and Okazaki, Ryota and Takata, Tomoaki and Moriyama, Mayuko and Takatani, Ayuko and Miyawaki, Yoshia and Shirai, Tsuyoshi and Dobashi, Hiroaki and Ito, Takafumi and Matsumoto, Isao and Takada, Toshihiko and Kawahito, Yutaka and Ito-Ihara, Toshiko and Kida, Takashi and Yajima, Nobuyuki and Kawaguchi, Takashi and Hirata, Shintaro},
title = {Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS)},
journal = {Rheumatology International},
year = {2025},
doi = {10.1007/s00296-025-06014-y}
}
EUVIMED